Compared to normal tissues, the methylation level of the HMGA2 promoter in endometrial cancer was significantly reduced, especially in stage III tumors, where the decrease was most pronounced, leading to reduced chromosomal stability and increased tumorigenesis (Supplementary Figures 1A, B). Here, HMGA2 is linked to endometrial cancer.